Trupanion Inc
F:TPW

Watchlist Manager
Trupanion Inc Logo
Trupanion Inc
F:TPW
Watchlist
Price: 26 EUR -1.52% Market Closed
Market Cap: €1.1B

Trupanion Inc
Investor Relations

Trupanion sells medical insurance for cats and dogs. Pet owners buy its policies to help cover unexpected veterinary bills, and the company focuses on accident-and-illness coverage rather than general pet services. Its business is built around a simple promise: pay part of the vet cost when a covered pet gets sick or injured. The company makes money mainly from recurring policy premiums. It sells directly to pet owners and also reaches customers through veterinarians, breeders, and other referral partners. Trupanion’s system is built to pay veterinarians directly at checkout when possible, which makes the claims process easier for both pet owners and clinics. What makes Trupanion different is that it sits in a very specific corner of the insurance market. It does not sell broad household insurance or many types of financial products; it focuses on pet medical coverage and the software and payment network that support it. That makes it both an insurer and a service provider in the veterinary care chain.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Aug 5, 2026
AI Summary
Q2 2026

Strong quarter: Trupanion said second-quarter revenue was $392.9 million, up 11% year over year, and adjusted operating income was $43.3 million, up 24% and ahead of expectations.

Pet growth: Gross pet adds accelerated 9% year over year, helping net subscription pets rise by about 18,800, or 39% versus last year.

Margin discipline: Subscription adjusted operating margin improved to 15.0% from 13.8% a year ago, helped by better pricing and lower spending as a share of revenue.

Guidance: Management narrowed full-year 2026 revenue and AOI ranges and slightly increased the midpoint of subscription revenue, keeping the outlook for about 14% subscription revenue growth.

Capital return: Trupanion announced a new $100 million share repurchase program after receiving approval to dividend $44 million of capital from an insurance subsidiary.

Product rollout: Expanded deductible and coinsurance options are gaining traction, with management saying the rollout is about 50% complete and will continue through the rest of the year.

Inflation: Veterinary inflation is still running at a double-digit pace, and management said pricing is still reflecting those higher costs even though inflation is easing.

Key Financials
Total revenue
$392.9 million
Subscription revenue
$276.7 million
Monthly average revenue per pet
$87.44
Subscription pets
1,125,000
Average monthly retention
98.37%
Cost of paying veterinary invoices
$194.3 million
Value proposition
70.2%
Variable expenses
9.0%
Fixed expenses
5.8%
Subscription adjusted operating income
$41.4 million
Subscription adjusted operating margin
15.0%
Other business revenue
$116.2 million
Other business adjusted operating income
$1.9 million
Total adjusted operating income
$43.3 million
Average pet acquisition cost
$299 per pet
Net income
$6.8 million
Earnings per share
$0.16 per basic and diluted share
Operating cash flow
$21 million
Capital expenditures
$1.8 million
Free cash flow
$19.2 million
Free cash flow over last four quarters
$82.2 million
Cash and short-term investments
$398.5 million
Debt balance
$106.9 million
Dividend from insurance entity
$44 million
Share repurchase program
$100 million
Gross pet adds
up 9% year over year
Net subscription pets added
approximately 18,800
Q3 2026 total revenue guidance
$399 million to $405 million
Q3 2026 subscription revenue guidance
$284 million to $287 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Fawwad Qureshi
Chief Finance Officer
No Bio Available
Mr. John Gallagher
Chief Operating Officer
No Bio Available
Dr. Steve Weinrauch BVMS, MRCVS
Executive Vice President of North America & Veterinary Strategy
No Bio Available
Mr. Wei Li
Senior VP of Finance & Corporate Controller
No Bio Available
Ms. Brenna McGibney
Chief Administrative Officer
No Bio Available
Ms. Laura Bainbridge
Head of Investor Relations
No Bio Available
Mr. Christopher John Kearns
Chief Legal Officer
No Bio Available
Ms. Bradley Lamb
Head of Conversion
No Bio Available
Ms. Emily Dreyer
Senior Vice President of Channel Growth
No Bio Available
Mr. Shawn McWashington
Head of Corporate Group Benefits
No Bio Available

Contacts

Address
WASHINGTON
Seattle
6100 4th Ave S Ste 200
Contacts
+18887332685.0
trupanion.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett